Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses the Phase 2 ONC201 Patient Selection and especially Pheochromocytoma and Paraganglioma patients.
Phase 2 ONC201 Patient Selection Pheochromocytoma and Paraganglioma – May Reduce Hypertension
